🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21581Original Research

Exercise combined with magnetic stimulation improves muscle strength and gait speed in patients with disuse-induced muscle atrophy of the lower limbs

SUN Shiqiang¹,BAI Shi¹,LI Wenhao¹,WANG Youpeng¹,DU Xinran¹,ZHANG Hao¹,LI Zhongshan¹

Department of Physical Education, Northeastern University, Shenyang 110819, Liaoning Province, China

Read Executive PreviewQuick FAQ
Exercise combined with magnetic stimulation improves muscle strength and gait speed in patients with disuse-induced muscle atrophy of the lower limbs
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1908, Issue 36 • pp. 100-112Citation:SUN Shiqiang et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Magnetic stimulation combined with exercise therapy significantly improves maximum voluntary contraction and reduces the difference rate between affected and healthy limbs in patients with disuse muscle atrophy after Achilles tendon rupture. • The combined intervention significantly enhances gait speed parameters, including Timed Up and Go test, 5-times sit-to-stand test, and 6 m normal walking speed. • The improvements in muscle strength and gait speed in the magnetic stimulation group were significantly greater than those in the control group, indicating an auxiliary synergistic effect. • Low-frequency pulsed magnetic stimulation (1.5 mT, 3 300 Hz) is a safe, non-invasive adjunct to exercise rehabilitation for disuse muscle atrophy.
Sponsored Research Highlight

Abstract

BACKGROUND: In recent years, magnetic stimulation therapy can activate the classical transient receptor potential channel 1, triggering the calcium-mitochondrial axis to enhance myogenesis and mitochondrial biogenesis in vivo, thereby recapitulating physiological adaptations related to exercise-induced metabolic responses. As an emerging technique for promoting muscle function, magnetic stimulation has gained widespread attention and validation in the rehabilitation of muscular diseases due to its advantages of being non-invasive, passive, and safe. However, there is a lack of clinical studies on the therapeutic efficacy of this technique in the treatment of disuse-induced muscle atrophy. OBJECTIVE: To investigate the therapeutic effect of exercise therapy combined with magnetic stimulation on the recovery of muscle strength and locomotor ability in patients with disuse-induced muscle atrophy of the lower limbs. METHODS: Sixteen patients with lower limb disuse muscle atrophy caused by prolonged bed rest after unilateral Achilles tendon rupture surgery were recruited and randomly divided into control group and experimental group, 8 cases in each group. The control group received traditional exercise rehabilitation therapy, including joint range of motion training, muscle strength training, and soft tissue stretching training, 3 times a week. The experimental group additionally received medical magnetic physical factor stimulation (intensity 1.5 mT, frequency 3 300 Hz, 48 h per session, 10 min each time) on this basis, with a total trial duration of 4 weeks. All subjects underwent maximum voluntary contraction (MVC) test of the lower limbs and gait speed measurements including Timed Up and Go test (TUG), 5-times sit-to-stand test (5STS), and 6 m normal walking speed test before and after intervention. RESULTS AND CONCLUSION: After 4 weeks of intervention, all 16 subjects completed the trial. In the experimental group, the maximum voluntary contraction of the affected lower limb (P=0.001) and the difference rate of MVC between affected and healthy sides (P=0.001) significantly decreased, and the improvements were superior to those in the control group. In terms of gait speed indicators, the experimental group showed significant improvements in TUG (P=0.038), 6 m normal walking speed (P=0.025), and 5STS (P=0.050) compared with baseline. Between-group comparison revealed that the experimental group had significantly greater improvements in MVC of the affected leg (P=0.003), difference rate of MVC between affected and healthy sides (P=0.004), TUG (P=0.019), and 6 m normal walking speed (P=0.011) than the control group. These data confirm that after 4 weeks of low-frequency pulsed magnetic field (1.5 mT, 3 300 Hz) combined with exercise therapy, patients with disuse muscle atrophy after Achilles tendon rupture showed significantly better improvements in MVC of the affected and healthy legs, TUG, and 6 m normal walking speed than the control group, demonstrating that magnetic stimulation combined with exercise therapy has an auxiliary synergistic effect on isometric muscle strength and lower limb motor function. Therefore, magnetic stimulation combined with exercise therapy can be used as a new means for rehabilitation of disuse muscle atrophy.

1. Introduction

Disuse muscle atrophy is a pathological change in skeletal muscle caused by mechanical unloading, characterized by decreased muscle fiber cross-sectional area, loss of myofibrillar protein, and decline in muscle function [1], significantly increasing the risk of falls and secondary injuries [2-4]. The pathogenesis involves an imbalance in multi-pathway molecular regulatory networks. At the molecular level, inhibition of the insulin-like growth factor 1-protein kinase B-mammalian target of rapamycin (IGF1-Akt-mTOR) signaling pathway leads to reduced ribosomal biogenesis efficiency [5], imbalance in calcium release and reuptake [6], and activation of the ubiquitin-proteasome system [7]. Current intervention strategies focus on antioxidant defense system reconstruction, mitochondrial function optimization, and regulation of protein metabolism dynamic balance.

Walking limitation caused by disuse muscle atrophy is an important trigger for the continuous deterioration of patients' health. To improve muscle function, early clinical treatment plans have used active and passive exercise therapy as an important means of rehabilitation [8], with its therapeutic mechanism involving dual regulation of mechanical signal transduction and mitochondrial function [9-10]. Mechanical load promotes muscle regeneration and enhances mitochondrial respiratory function by activating mTOR, satellite cells, and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) [11], thereby inhibiting the progression of muscle atrophy [12]. Postoperative pain leading to inability to bear exercise load is a major limiting factor for exercise therapy, affecting muscle function and walking ability recovery. In this context, magnetic physical factor therapy based on muscle function enhancement shows important clinical translational value. Low-frequency pulsed magnetic field, as an emerging non-invasive physical factor intervention, has gained widespread attention in the rehabilitation of muscle diseases due to its advantages of being non-invasive, passive, and safe.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
SUN Shiqiang, BAI Shi, LI Wenhao, WANG Youpeng, DU Xinran, ZHANG Hao, LI Zhongshan (2026). Exercise combined with magnetic stimulation improves muscle strength and gait speed in patients with disuse-induced muscle atrophy of the lower limbs. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21581
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is disuse muscle atrophy?

Disuse muscle atrophy is a pathological condition of skeletal muscle caused by prolonged bed rest, immobilization, or lack of mechanical loading. It is characterized by reduced muscle fiber cross-sectional area, decreased muscle strength, and imbalance in protein synthesis and degradation, along with mitochondrial dysfunction and impaired neuromuscular control.

How does magnetic stimulation work in muscle rehabilitation?

Magnetic stimulation activates the classical transient receptor potential channel 1 (TRPC1), triggering the calcium-mitochondrial signaling pathway, which upregulates key molecules such as PGC-1α. This improves mitochondrial function, enhances energy metabolism, and promotes myogenic differentiation, thereby facilitating muscle recovery.

What were the main findings of the study?

The study found that after 4 weeks of low-frequency pulsed magnetic stimulation (1.5 mT, 3 300 Hz) combined with exercise therapy, patients with disuse muscle atrophy after Achilles tendon rupture showed significantly greater improvements in maximum voluntary contraction, Timed Up and Go test, and 6 m normal walking speed compared to exercise therapy alone.

What is the significance of combining magnetic stimulation with exercise therapy?

Combining magnetic stimulation with exercise therapy provides an auxiliary synergistic effect, enhancing isometric muscle strength and lower limb motor function. This approach offers a non-invasive, passive, and safe adjunct to traditional rehabilitation, potentially improving outcomes in patients with disuse muscle atrophy.

What are the clinical implications of this research?

The findings suggest that magnetic stimulation combined with exercise therapy can be used as a new rehabilitation strategy for disuse muscle atrophy, particularly in patients who cannot tolerate high-intensity exercise due to postoperative pain. It may help accelerate recovery of muscle strength and gait speed, reducing the risk of falls and secondary injuries.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF